Literature DB >> 21214581

Use of hemovigilance data to evaluate the effectiveness of diversion and bacterial detection.

Pierre Robillard1, Gilles Delage, Nawej Karl Itaj, Mindy Goldman.   

Abstract

BACKGROUND: Several preventive measures, including diversion of the first aliquot of blood and culturing of platelet (PLT) components, have been implemented to decrease the risk of transfusion-transmitted bacterial infections (TTBIs). We evaluated the effectiveness of these measures in Québec using hemovigilance data from January 2000 to December 2008. STUDY DESIGN AND METHODS: Adverse transfusion reactions were reported to the Québec Ministry of Health by transfusion safety officers. Initial aliquot diversion, already in place for apheresis PLTs, was added to all whole blood collections in early 2003. Bacterial detection was implemented in March 2003 for apheresis PLTs and February 2005 for whole blood-derived PLTs (WBDPs).
RESULTS: The incidence of probable and definite TTBIs associated with WBDPs decreased from 1 in 2655 to 1 in 27,737 five-unit pools (p = 0.004) after implementation of diversion. There were no reports of TTBIs with WBDPs after culture was added to diversion, further reducing the risk to 1 in 58,123 five-unit pools (p < 0.001). There was only one TTBI associated with apheresis PLTs during the 9-year period, which occurred after implementation of both diversion and culture.
CONCLUSION: Hemovigilance data demonstrated a highly significant decrease in TTBIs associated with WBDPs, mainly attributed to the implementation of diversion. However, diversion and culture do not totally abolish the risk of TTBIs.
© 2010 American Association of Blood Banks.

Entities:  

Mesh:

Year:  2011        PMID: 21214581     DOI: 10.1111/j.1537-2995.2010.03001.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  6 in total

1.  Transfusion-Transmitted Bacterial Infections - Haemovigilance Data of German Blood Establishments (1997-2010).

Authors:  Markus B Funk; Annette Lohmann; Serife Guenay; Olaf Henseler; Margarethe Heiden; Kay-Martin O Hanschmann; Brigitte Keller-Stanislawski
Journal:  Transfus Med Hemother       Date:  2011-07-08       Impact factor: 3.747

2.  How is national recipient hemovigilance conducted in the United States?

Authors:  Koo-Whang Chung; Alexis Harvey; Sridhar V Basavaraju; Matthew J Kuehnert
Journal:  Transfusion       Date:  2015-01-07       Impact factor: 3.157

3.  Bordetella holmesii Contamination of Platelet Concentrates: Revisiting the Definition of a Positive Culture.

Authors:  Gilles Delage; Louis Thibault; Marc Cloutier; Marie-Ève Nolin; Hana Daoud; Annie Jacques; Marie Joëlle de Grandmont; Éric Ducas
Journal:  J Clin Microbiol       Date:  2018-11-27       Impact factor: 5.948

4.  Transfusion and risk of infection in Canada: Update 2012.

Authors:  Noni E Macdonald; Sheila F O'Brien; Gilles Delage
Journal:  Paediatr Child Health       Date:  2012-12       Impact factor: 2.253

5.  Phased implementation of pathogen-reduced platelets in a health system facilitates increased manufacturing at the blood center.

Authors:  Elizabeth S Allen; Colleen Vincent; David A Reeve; Patricia M Kopko
Journal:  Transfusion       Date:  2019-08-13       Impact factor: 3.157

Review 6.  Serious Hazards of Transfusion (SHOT) haemovigilance and progress is improving transfusion safety.

Authors:  Paula H B Bolton-Maggs; Hannah Cohen
Journal:  Br J Haematol       Date:  2013-09-14       Impact factor: 6.998

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.